CD59 and metabolic disease: Similarly, human hepatocytes are characterized by high expression of a battery of complement inhibitors, including CD46, CD55, CD59, and factor H [52,53], although it is not known whether their expression is stable in metabolic disorders such as obesity or cachexia.